Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 28 03:05PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.30 Insider Own4.67% Shs Outstand4.07M Perf Week-24.69%
Market Cap7.20M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.88M Perf Month-26.86%
Income-9.28M PEG- EPS next Q- Inst Own1.43% Short Float / Ratio0.17% / 1.05 Perf Quarter-34.93%
Sales0.00M P/S- EPS this Y- Inst Trans-45.45% Short Interest0.01M Perf Half Y-39.18%
Book/sh3.73 P/B0.47 EPS next Y- ROA-39.81% Target Price10.00 Perf Year-51.54%
Cash/sh2.58 P/C0.69 EPS next 5Y- ROE-46.90% 52W Range1.55 - 4.45 Perf YTD-49.17%
Dividend- P/FCF- EPS past 5Y20.43% ROI-60.84% 52W High-60.23% Beta1.04
Dividend %- Quick Ratio6.17 Sales past 5Y0.00% Gross Margin- 52W Low14.19% ATR0.22
Employees11 Current Ratio6.17 Sales Q/Q- Oper. Margin0.00% RSI (14)37.91 Volatility9.68% 6.65%
OptionableNo Debt/Eq0.01 EPS Q/Q14.33% Profit Margin- Rel Volume1.07 Prev Close1.73
ShortableYes LT Debt/Eq0.00 EarningsAug 31 AMC Payout- Avg Volume6.14K Price1.77
Recom1.00 SMA20-24.01% SMA50-28.53% SMA200-37.47% Volume5,948 Change2.31%
Nov-27-23 07:25AM
Nov-16-23 07:25AM
Nov-08-23 07:25AM
Oct-30-23 07:25AM
Aug-31-23 07:25AM
07:25AM Loading…
Aug-23-23 07:25AM
Aug-22-23 07:25AM
Aug-15-23 07:25AM
Jul-31-23 07:52AM
Jul-26-23 07:25AM
Jun-21-23 07:25AM
May-30-23 07:25AM
May-19-23 07:25AM
May-10-23 07:25AM
07:25AM Loading…
Apr-26-23 07:25AM
Apr-04-23 07:25AM
Mar-16-23 07:25AM
Mar-14-23 07:25AM
Mar-08-23 07:25AM
Feb-16-23 04:44PM
Jan-31-23 07:25AM
Jan-30-23 07:25AM
Jan-25-23 07:25AM
Jan-20-23 09:40AM
Jan-09-23 10:25AM
Jan-06-23 07:25AM
Jan-03-23 10:25AM
Dec-29-22 10:25AM
Nov-07-22 10:25AM
07:25AM Loading…
Oct-28-22 07:25AM
Oct-26-22 07:25AM
Oct-13-22 10:25AM
Sep-26-22 07:25AM
Sep-20-22 07:25AM
Aug-25-22 07:25AM
Aug-08-22 04:00PM
Jul-22-22 07:25AM
Jul-06-22 11:00AM
Jun-24-22 08:35AM
Jun-23-22 11:00AM
Jun-21-22 04:21PM
Jun-20-22 07:05AM
Jun-02-22 08:00AM
May-31-22 08:27AM
Apr-27-22 07:40AM
Apr-06-22 09:34PM
Jan-28-22 11:02AM
Jan-27-22 07:45AM
Jan-06-22 07:30AM
Jan-05-22 07:45AM
Dec-14-21 07:25AM
Nov-22-21 07:50AM
Nov-09-21 07:30AM
Nov-05-21 02:57AM
Nov-04-21 07:30AM
Oct-29-21 02:50AM
Oct-19-21 05:08PM
Sep-20-21 10:51AM
Aug-04-21 08:39AM
Jul-30-21 09:05AM
Jul-15-21 09:52AM
Jul-01-21 11:51AM
Jun-23-21 09:21AM
Jun-07-21 11:04AM
Apr-29-21 08:30AM
Apr-21-21 09:25AM
Feb-26-21 07:45AM
Feb-09-21 08:53AM
Jan-07-21 08:00AM
Dec-21-20 08:30AM
Dec-09-20 09:46AM
Nov-16-20 10:42AM
Oct-26-20 10:03PM
Aug-05-20 03:10PM
Aug-04-20 09:07AM
Aug-03-20 09:33PM
Jul-30-20 06:49PM
Jul-01-20 08:12AM
Jun-29-20 11:14PM
May-20-20 08:58PM
Apr-30-20 04:35AM
Apr-21-20 05:50PM
Feb-21-20 07:15PM
Nov-11-19 10:30PM
Sep-12-19 11:07PM
Jul-29-19 08:00AM
Jul-11-19 09:31PM
May-06-19 08:00AM
May-03-19 08:00AM
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson's, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.